# Evaluation of HRQoL in Adult With Immune Thrombocytopenia in China

> **NCT03324087** · — · UNKNOWN · sponsor: **Shandong University** · enrollment: 1000 (estimated)

## Conditions studied

- Immune Thrombocytopenia

## Interventions

- **DIAGNOSTIC_TEST:** HRQoL

## Key facts

- **NCT ID:** NCT03324087
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-01
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2017-10-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03324087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03324087, "Evaluation of HRQoL in Adult With Immune Thrombocytopenia in China". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03324087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*